SCHEMBL24492900

SCHEMBL24492900

c1ccc(-n2c3ccncc3c3cc(-c4cc(-c5cccc(-c6cccc(-c7cccnc7)c6)c5)cc(-c5cccc(-c6cccc(-c7cccnc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.42
▸ CYP11B1 P15538 3/20 0.42
▸ CYP11B2 P19099 3/20 0.42
▸ CYP17A1 P05093 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ PSIP1 O75475 1/20 0.40
▸ AXL P30530 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ NR4A2 P43354 1/20 0.40
▸ PGR P06401 1/20 0.40
▸ KMO O15229 1/20 0.40
▸ CYP3A4 P08684 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ RAF1 P04049 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493047 0.97 CYP19A1 (0.40) CYP19A1CYP11B1CYP11B2CYP17A1ALDH1A1
SCHEMBL24492823 0.91 ATM (0.39) ALDH1A1MEN1KMT2ADRD2CYP3A4
SCHEMBL24493057 0.91 L3MBTL1 (0.47) CYP19A1CYP11B1CYP11B2CYP17A1ALDH1A1
SCHEMBL24492822 0.91 MKNK1 (0.42) MEN1PIK3CAKMT2AMKNK1MAPT
SCHEMBL24492835 0.91 CYP19A1 (0.46) CYP19A1CYP11B1CYP11B2CYP17A1ALDH1A1
SCHEMBL24492873 0.90 MKNK1 (0.39) CYP19A1CYP11B1CYP11B2MEN1PIK3CA
SCHEMBL15369824 0.90 CYP19A1 (0.54) CYP19A1CYP11B1CYP11B2CYP17A1ALDH1A1
SCHEMBL25946455 0.89 ATM (0.42) ALDH1A1MEN1PIK3CAKMT2AMKNK1
SCHEMBL15945614 0.89 KDM4E (0.44) ALDH1A1CYP1A2FGFR1GSK3BDYRK1A
SCHEMBL24492826 0.89 KDM4E (0.45) CYP19A1CYP11B1CYP11B2CYP17A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 CYP19A1 2451/4885CYP11B1 1868/4885CYP11B2 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback